---
title: "Real-World Evidence"
description: "1 posts about Real-World Evidence, summarised, each linking to the original."
---

# Real-World Evidence
> 1 posts about Real-World Evidence, summarised, each linking to the original.

## Articles

### [Real-world evidence for medical affairs: who can actually use it?](https://yomu.fyi/post/real-world-evidence-for-medical-affairs-who-can-actually-use-it.md)
- Company: [Databricks](https://yomu.fyi/company/databricks.md)
- Author: Adam Crown
- Published: May 8, 2026

Real-World Evidence (RWE) is increasingly sought by payers, providers, and regulators, but the post distinguishes it from abundant Real-World Data (RWD), which must undergo rigorous study design, analysis, and interpretation to become credible evidence. It identifies four Medical Affairs use cases: regulatory submissions and commitments, payer formulary discussions, rapid HCP scientific exchange, and internal pipeline or portfolio decisions. The stated operational problem is that teams with claims, EHR, registry, and other assets often lack the fluency or capacity to answer complex questions within competitive and regulatory timelines. Databricks Genie is presented as a natural-language interface that can query unified RWE assets, including a treatment-initiation and 12-month-persistence example that reportedly surfaces in seconds rather than requiring several days of data-science work. The post also describes governance, logged and attributable requests, treatment-pathway awareness, and access controls for MSL support.